Search company, investor...


Founded Year



Acquired | Acquired

Total Raised


About PathoLase

PathoLase, Inc. is a group of professionals, in the medical & biophotonic fields, developing light-based disinfectant devices and procedures to treat diseases caused by viral, bacterial & fungal pathogens in human tissue. The company are currently developing and licensing proven procedures and associated devices for the eradication of the fungus (Trichophyton rubrum) which is the primary pathogen responsible for toe nail fungus (Onychomycosis), currently affecting 10 million individuals in the US.

Headquarters Location

275 Airpark Boulevard Suite 500

Chico, California, 95973,

United States


Missing: PathoLase's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: PathoLase's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

PathoLase Frequently Asked Questions (FAQ)

  • When was PathoLase founded?

    PathoLase was founded in 2004.

  • Where is PathoLase's headquarters?

    PathoLase's headquarters is located at 275 Airpark Boulevard, Chico.

  • What is PathoLase's latest funding round?

    PathoLase's latest funding round is Acquired.

  • How much did PathoLase raise?

    PathoLase raised a total of $6M.

  • Who are the investors of PathoLase?

    Investors of PathoLase include NuvoLase and Nexus Medical Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.